C4X Discovery

C4X Discovery (C4XD) is a UK drug discovery company developing small molecule drug candidates using its proprietary computational and structural chemistry platform.

It applies enhanced candidate molecule design and patient stratification capabilities to generate drug candidates across immuno-inflammatory disease areas.

It maintains a portfolio spanning early-stage target opportunities to late-stage programmes, with multiple candidates partnered with pharmaceutical companies.

C4XD is based in Manchester and is listed on AIM.